Larry M. Tiffany
Presidente presso Medcura, Inc.
Posizioni attive di Larry M. Tiffany
Società | Posizione | Inizio | Fine |
---|---|---|---|
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Presidente | - | - |
Amministratore Delegato | - | 06/06/2022 |
Storia della carriera di Larry M. Tiffany
Precedenti posizioni note di Larry M. Tiffany
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Corporate Officer/Principal | - | 14/09/2008 |
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Corporate Officer/Principal | 01/06/2006 | 03/01/2008 |
Genetraks Pty Ltd.
Genetraks Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Pty Ltd. operates as an Australian development stage company. The private company is based in TOOWONG, Australia. | Corporate Officer/Principal | - | - |
DioGenix, Inc.
DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Direttore/Membro del Consiglio | 01/09/2008 | - |
Amministratore Delegato | 01/09/2008 | - | |
Fondatore | 01/09/2008 | - | |
Presidente | 01/09/2008 | - |
Formazione di Larry M. Tiffany
The Johns Hopkins University | Graduate Degree |
Nazareth College of Rochester (New York) | Undergraduate Degree |
University of New Hampshire School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Australia | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Graduate Degree | 2 |
Settori
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Gene Logic, Inc.
Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland. | Health Technology |
Ore Pharmaceuticals, Inc.
Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA. | Health Technology |
DioGenix, Inc.
DioGenix, Inc. Medical SpecialtiesHealth Technology DioGenix, Inc. develops and commercializes novel, non-invasive diagnostic, prognostic and treatment response monitoring tests. Its program is designed to provide neurologists with a comprehensive set of clinical tests to diagnose early-stage MS, segment MS patients into clinical sub-types and predict response to treatment, all using non-invasive blood tests. The company was founded by Cam Gallagher, Douglas W. Bigwood and Larry M. Tiffany in September 2008 and is headquartered in Gaithersburg, MD. | Health Technology |
Genetraks Pty Ltd.
Genetraks Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Genetraks Pty Ltd. operates as an Australian development stage company. The private company is based in TOOWONG, Australia. | Commercial Services |
Medcura, Inc.
Medcura, Inc. Medical SpecialtiesHealth Technology Medcura, Inc. develops novel line of hemostatic and wound treatment products. The firm?s products include vascular gel-e, nuisance bleed, chronic wound, and surgical gel-e. The company was founded by Matthew Dowling in January 2013 and is headquartered in Riverdale, MD. | Health Technology |
- Borsa valori
- Insiders
- Larry M. Tiffany
- Esperienza